News date: 22 April 2019
Ilyashev & Partners International Trade Practice team, headed by Partner Olena Omelchenko, has successfully protected the interests of a large Indian manufacturer of sterile hypodermic single use syringes Lifelong Meditech Private Limited in the anti-dumping investigation on imports into Ukraine of syringes originating from the Republic of India, the Republic of Turkey and the People’s Republic of China.
At the meeting on April 17, 2019 the Interdepartmental Commission on International Trade decided not to apply any measures to the products of Lifelong Meditech Private Limited. Thus, the interests of both Indian producer and Ukrainian consumers were taken into account.
“Non-application of measures regarding all parties is an extremely rare result for an anti-dumping investigation,” – said Olena Omelchenko, Partner of Ilyashev & Partners Law Firm, Head of International Trade Practice, – Since our client is the main supplier of syringes from the Republic of India to Ukraine, the Commission’s decision fully satisfies him.”.
It should be reminded that the decision to initiate an anti-dumping investigation was made by the Commission on October 25, 2017 after consideration of the complaints lodged by “Hemoplast” PJSC and “Tyumen-Mediko-Smila” Private JSC.
Lifelong Meditech Private Limited was founded in 2005 and is part of the international diversified industrial Lifelong group. The company produces sterile hypodermic single use syringes, sterile hypodermic single use needles and infusion sets. Lifelong Meditech Private Limited markets its products under Safeway & Lifelong brands and is the second largest producer of syringes in India with an installed capacity of 720 million syringes per annum.